CME shares rose 1.4% this afternoon to a price of $281.67. The stock is still trading within range of its average target price of $271.12, and over the last 52 weeks, it has recorded a 31.4% performance. Analysts have given the Large-Cap Capital Markets stock target prices ranging from $211.0 to $305.0 dollars per share, with an average rating of hold.
The stock has a very low short interest at 1.4%, and a short ratio of 1.67. The company's insiders own 0.45% of its outstanding shares, which indicates a strong alignment between management and shareholder interests. Finally, we also note that a significant number of institutional investors are invested in the stock, with 91.8% of CME's shares being owned by this investor type.
Institutions Invested in CME
| Date Reported | Holder | Percentage | Shares | Value |
|---|---|---|---|---|
| 2025-03-31 | Vanguard Group Inc | 10% | 34,643,827 | $9,758,127,216 |
| 2025-03-31 | Blackrock Inc. | 9% | 32,605,744 | $9,184,060,350 |
| 2025-03-31 | State Street Corporation | 5% | 16,439,164 | $4,630,419,544 |
| 2025-03-31 | JPMORGAN CHASE & CO | 3% | 12,574,112 | $3,541,750,295 |
| 2025-03-31 | Morgan Stanley | 3% | 10,562,859 | $2,975,240,636 |
| 2025-03-31 | Capital World Investors | 3% | 9,726,423 | $2,739,641,697 |
| 2025-03-31 | Geode Capital Management, LLC | 2% | 8,858,782 | $2,495,253,244 |
| 2025-03-31 | Bank Of New York Mellon Corporation | 2% | 6,176,107 | $1,739,624,141 |
| 2025-03-31 | Price (T.Rowe) Associates Inc | 2% | 5,448,310 | $1,534,625,550 |
| 2024-12-31 | NORGES BANK | 1% | 4,768,500 | $1,343,143,459 |
Besides an analyst consensus of little upside potential, other market factors point to there being mixed market sentiment on CME.
